Botulinum toxin treatment of facial myoclonus in suspected Rasmussen encephalitis
Identifieur interne : 003556 ( Main/Exploration ); précédent : 003555; suivant : 003557Botulinum toxin treatment of facial myoclonus in suspected Rasmussen encephalitis
Auteurs : Nina Browner [États-Unis] ; Shaheda N. Azher [États-Unis] ; Joseph Jankovic [États-Unis]Source :
- Movement Disorders [ 0885-3185 ] ; 2006-09.
Descripteurs français
- Pascal (Inist)
English descriptors
- KwdEn :
- Adult, Anticonvulsants (administration & dosage), Atrophy, Bontoxilysin, Botulinum Toxins, Type A (administration & dosage), Caudate Nucleus (pathology), Cerebral Cortex (pathology), Dominance, Cerebral (physiology), Drug Resistance, Encephalitis, Encephalitis (drug therapy), Epilepsia Partialis Continua (drug therapy), Epilepsies, Myoclonic (drug therapy), Facial Muscles (drug effects), Female, Humans, Injections, Intramuscular, Myoclonus, Nervous system diseases, Rasmussen encephalitis, Treatment, Treatment Outcome, botulinum toxin, myoclonus.
- MESH :
- chemical , administration & dosage : Anticonvulsants, Botulinum Toxins, Type A.
- drug effects : Facial Muscles.
- drug therapy : Encephalitis, Epilepsia Partialis Continua, Epilepsies, Myoclonic.
- pathology : Caudate Nucleus, Cerebral Cortex.
- physiology : Dominance, Cerebral.
- Adult, Atrophy, Drug Resistance, Female, Humans, Injections, Intramuscular, Treatment Outcome.
Abstract
Patients with Rasmussen encephalitis (RE) may develop a variety of involuntary movements. We report a 26‐year‐old woman who presented with a 3‐year history of progressive, continuous myoclonus of the left side of the face and left arm as well as left spastic hemiparesis. Magnetic resonance imaging of the brain showed right hemisphere and basal ganglia atrophy, and 24‐hour electroencephalogram demonstrated diffuse slowing with random sharp waves in both hemispheres. An 18‐fluoro‐deoxy‐glucose positron emission tomography scan indicated hypometabolism of the right cerebral hemisphere, including basal ganglia and thalamus. We successfully treated her myoclonus with injections of botulinum toxin A into the left zygomaticus muscle. © 2006 Movement Disorder Society
Url:
DOI: 10.1002/mds.20991
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 003719
- to stream Istex, to step Curation: 003719
- to stream Istex, to step Checkpoint: 002017
- to stream PubMed, to step Corpus: 002C07
- to stream PubMed, to step Curation: 002C07
- to stream PubMed, to step Checkpoint: 002E45
- to stream Ncbi, to step Merge: 001727
- to stream Ncbi, to step Curation: 001727
- to stream Ncbi, to step Checkpoint: 001727
- to stream Main, to step Merge: 004871
- to stream PascalFrancis, to step Corpus: 001984
- to stream PascalFrancis, to step Curation: 001337
- to stream PascalFrancis, to step Checkpoint: 001C05
- to stream Main, to step Merge: 004D00
- to stream Main, to step Curation: 003556
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Botulinum toxin treatment of facial myoclonus in suspected Rasmussen encephalitis</title><author><name sortKey="Browner, Nina" sort="Browner, Nina" uniqKey="Browner N" first="Nina" last="Browner">Nina Browner</name></author><author><name sortKey="Azher, Shaheda N" sort="Azher, Shaheda N" uniqKey="Azher S" first="Shaheda N." last="Azher">Shaheda N. Azher</name></author><author><name sortKey="Jankovic, Joseph" sort="Jankovic, Joseph" uniqKey="Jankovic J" first="Joseph" last="Jankovic">Joseph Jankovic</name><affiliation><country>États-Unis</country><placeName><settlement type="city">Houston</settlement><region type="state">Texas</region></placeName><orgName type="university" n="3">Baylor College of Medicine</orgName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:3CA3D2F18756053E6ADD1E254A6C47D714F100CD</idno><date when="2006" year="2006">2006</date><idno type="doi">10.1002/mds.20991</idno><idno type="url">https://api.istex.fr/document/3CA3D2F18756053E6ADD1E254A6C47D714F100CD/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">003719</idno><idno type="wicri:Area/Istex/Curation">003719</idno><idno type="wicri:Area/Istex/Checkpoint">002017</idno><idno type="wicri:doubleKey">0885-3185:2006:Browner N:botulinum:toxin:treatment</idno><idno type="wicri:source">PubMed</idno><idno type="RBID">pubmed:16758485</idno><idno type="wicri:Area/PubMed/Corpus">002C07</idno><idno type="wicri:Area/PubMed/Curation">002C07</idno><idno type="wicri:Area/PubMed/Checkpoint">002E45</idno><idno type="wicri:Area/Ncbi/Merge">001727</idno><idno type="wicri:Area/Ncbi/Curation">001727</idno><idno type="wicri:Area/Ncbi/Checkpoint">001727</idno><idno type="wicri:doubleKey">0885-3185:2006:Browner N:botulinum:toxin:treatment</idno><idno type="wicri:Area/Main/Merge">004871</idno><idno type="wicri:source">INIST</idno><idno type="RBID">Pascal:06-0518112</idno><idno type="wicri:Area/PascalFrancis/Corpus">001984</idno><idno type="wicri:Area/PascalFrancis/Curation">001337</idno><idno type="wicri:Area/PascalFrancis/Checkpoint">001C05</idno><idno type="wicri:doubleKey">0885-3185:2006:Browner N:botulinum:toxin:treatment</idno><idno type="wicri:Area/Main/Merge">004D00</idno><idno type="wicri:Area/Main/Curation">003556</idno><idno type="wicri:Area/Main/Exploration">003556</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Botulinum toxin treatment of facial myoclonus in suspected Rasmussen encephalitis</title><author><name sortKey="Browner, Nina" sort="Browner, Nina" uniqKey="Browner N" first="Nina" last="Browner">Nina Browner</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurology, Cleveland Clinic Foundation, Cleveland, Ohio</wicri:regionArea><placeName><region type="state">Ohio</region></placeName></affiliation></author><author><name sortKey="Azher, Shaheda N" sort="Azher, Shaheda N" uniqKey="Azher S" first="Shaheda N." last="Azher">Shaheda N. Azher</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Parkinson's Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, Texas</wicri:regionArea><placeName><region type="state">Texas</region></placeName></affiliation></author><author><name sortKey="Jankovic, Joseph" sort="Jankovic, Joseph" uniqKey="Jankovic J" first="Joseph" last="Jankovic">Joseph Jankovic</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Parkinson's Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, Texas</wicri:regionArea><placeName><region type="state">Texas</region></placeName><placeName><settlement type="city">Houston</settlement><region type="state">Texas</region></placeName><orgName type="university" n="3">Baylor College of Medicine</orgName></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="sub">Official Journal of the Movement Disorder Society</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2006-09">2006-09</date><biblScope unit="vol">21</biblScope><biblScope unit="issue">9</biblScope><biblScope unit="page" from="1500">1500</biblScope><biblScope unit="page" to="1502">1502</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">3CA3D2F18756053E6ADD1E254A6C47D714F100CD</idno><idno type="DOI">10.1002/mds.20991</idno><idno type="ArticleID">MDS20991</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Anticonvulsants (administration & dosage)</term><term>Atrophy</term><term>Bontoxilysin</term><term>Botulinum Toxins, Type A (administration & dosage)</term><term>Caudate Nucleus (pathology)</term><term>Cerebral Cortex (pathology)</term><term>Dominance, Cerebral (physiology)</term><term>Drug Resistance</term><term>Encephalitis</term><term>Encephalitis (drug therapy)</term><term>Epilepsia Partialis Continua (drug therapy)</term><term>Epilepsies, Myoclonic (drug therapy)</term><term>Facial Muscles (drug effects)</term><term>Female</term><term>Humans</term><term>Injections, Intramuscular</term><term>Myoclonus</term><term>Nervous system diseases</term><term>Rasmussen encephalitis</term><term>Treatment</term><term>Treatment Outcome</term><term>botulinum toxin</term><term>myoclonus</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Anticonvulsants</term><term>Botulinum Toxins, Type A</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Facial Muscles</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Encephalitis</term><term>Epilepsia Partialis Continua</term><term>Epilepsies, Myoclonic</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Caudate Nucleus</term><term>Cerebral Cortex</term></keywords><keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Dominance, Cerebral</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Atrophy</term><term>Drug Resistance</term><term>Female</term><term>Humans</term><term>Injections, Intramuscular</term><term>Treatment Outcome</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Bontoxilysin</term><term>Encéphalite</term><term>Myoclonie</term><term>Système nerveux pathologie</term><term>Traitement</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Patients with Rasmussen encephalitis (RE) may develop a variety of involuntary movements. We report a 26‐year‐old woman who presented with a 3‐year history of progressive, continuous myoclonus of the left side of the face and left arm as well as left spastic hemiparesis. Magnetic resonance imaging of the brain showed right hemisphere and basal ganglia atrophy, and 24‐hour electroencephalogram demonstrated diffuse slowing with random sharp waves in both hemispheres. An 18‐fluoro‐deoxy‐glucose positron emission tomography scan indicated hypometabolism of the right cerebral hemisphere, including basal ganglia and thalamus. We successfully treated her myoclonus with injections of botulinum toxin A into the left zygomaticus muscle. © 2006 Movement Disorder Society</div></front></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>Ohio</li><li>Texas</li></region><settlement><li>Houston</li></settlement><orgName><li>Baylor College of Medicine</li></orgName></list><tree><country name="États-Unis"><region name="Ohio"><name sortKey="Browner, Nina" sort="Browner, Nina" uniqKey="Browner N" first="Nina" last="Browner">Nina Browner</name></region><name sortKey="Azher, Shaheda N" sort="Azher, Shaheda N" uniqKey="Azher S" first="Shaheda N." last="Azher">Shaheda N. Azher</name><name sortKey="Jankovic, Joseph" sort="Jankovic, Joseph" uniqKey="Jankovic J" first="Joseph" last="Jankovic">Joseph Jankovic</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003556 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003556 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:3CA3D2F18756053E6ADD1E254A6C47D714F100CD
|texte= Botulinum toxin treatment of facial myoclonus in suspected Rasmussen encephalitis
}}
| This area was generated with Dilib version V0.6.23. |  |